Skip to content

Comprehensive Assessment of Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis

Comprehensive Assessment of Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03813017
Enrollment
100
Registered
2019-01-23
Start date
2019-10-31
Completion date
2020-07-31
Last updated
2019-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis, Coronary, Cardiovascular Diseases, Rheumatoid Arthritis

Brief summary

Cardiovascular disease is a leading cause for morbidity and mortality in general population. The incidence of cardiovascular disease and their poor outcome is well documented in a broad spectrum of connective tissue diseases, especially in rheumatoid arthritis (RA). The risk of incident CVD is increased by 48% in patients with RA compared to the general population. RA is associated with 50% increase in the mortality in patients with cardiovascular disease (CVD). One reason is the more frequent cardiovascular risk factors in RA patients compared with the general population. Patients with RA have a high risk of premature cardiovascular disease (CVD). The aim of the present study is to assess whether there are non-invasive measures that might predict arteriosclerosis in RA patients.

Interventions

None listed

Sponsors

Ziv Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. 18-70 years old (except for women till 75 years old) 2. Absence of established CVD: * Myocardial Infarction p/h * PCI with balloon and/or stent * Intermittent claudication * PAD / intervention * CAS /intervention 3. Signed informed consent form 4. Documented diagnosis of rheumatoid arthritis

Exclusion criteria

1. Known CVD 2. Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Cardiovascular disease risks in patient with theumatoid arthritis6 monthsPrediction of cardiovascular risks and proposed preventive treatment

Contacts

Primary ContactNaaem Simaan, Dr
naaem.s@ziv.health.gov.il+972523675305
Backup ContactKarine Beiruti, PhD
karine.b@ziv.health.gov.il+972528082424

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026